Phillip A Sharp
Director at Alnylam Pharmaceuticals, Inc. (ALNY)
Phillip A Sharp has filed 13 insider reports with the SEC since May 2021, as director at Alnylam Pharmaceuticals, Inc. (ALNY), director at Vir Biotechnology, Inc. (VIR) and director at Syros Pharmaceuticals, Inc. (SYRS). Phillip A Sharp made no open-market purchases or sales in the last 12 months. In the latest filing, on January 24, 2025, Phillip A Sharp sold 11,250 shares of Alnylam Pharmaceuticals, Inc. (ALNY) for $3.09M at an average of $275.00.
- Filings
- 13
- Companies
- 3
- Bought on market
- None
- Sold on market
- $15.4M
Companies where Phillip A Sharp is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | 0 | $15.4M | $147.82 | Jan 24, 2025 | |||
| Director | 121,174 | $8.87 | Jul 10, 2024 | ||||
| Director | Jun 2, 2022 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jan 23, 2025-$3.09MALNYDirector Sharp Phillip A sold $3,093,750 worth of shares (11,250 units at $275.00) and exercised 11,250 shares at a strike of $131.21Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jul 10, 2024~$241KVIRPhillip A Sharp plans to sell 25,897 shares (~$241K)Form 144Planned sale
- May 16, 2024ALNYSEC Form 4 filed by Sharp Phillip AForm 4Grant or award
- Feb 29, 2024-$4.54MALNYSharp Phillip A exercised 30,000 shares at a strike of $59.25 and sold $4,540,071 worth of shares (30,000 units at $151.34)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- May 22, 2023VIRSEC Form 4 filed by Sharp Phillip AForm 4Grant or award
- May 18, 2023ALNYSEC Form 4 filed by Sharp Phillip AForm 4Grant or award
- Aug 15, 2022-$7.76MALNYSEC Form 4: Sharp Phillip A exercised 33,670 shares at a strike of $33.77 and sold $7,760,736 worth of shares (33,670 units at $230.49) as part of a pre-agreed trading planForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jun 1, 2022SYRSSEC Form 4 filed by Sharp Phillip AForm 4Grant or award
- May 23, 2022VIRSEC Form 4: Sharp Phillip A was granted 6,405 shares, increasing direct ownership by 6% to 115,147 unitsForm 4Grant or award
- May 18, 2022ALNYSEC Form 4 filed by Sharp Phillip AForm 4Grant or award
- Jul 15, 2021ALNYSEC Form 4 filed by SHARP PHILLIP AForm 4Grant or award
- Jun 8, 2021SYRSSEC Form 4 filed by SHARP PHILLIP AForm 4Grant or award
- May 21, 2021VIRSEC Form 4: SHARP PHILLIP A was granted 3,374 units of Common Stock, increasing direct ownership by 3% to 108,742 unitsForm 4Grant or award
Also sits on boards with
Officers and directors who share two or more companies with Phillip A Sharp.
Compare Phillip A Sharp with
- Phillip A Sharp vs Charles Elliott Sigal2 shared
- Phillip A Sharp vs Marsha Fanucci2 shared
- Phillip A Sharp vs Yvonne Greenstreet1 shared
- Phillip A Sharp vs Aziz Sawaf1 shared
- Phillip A Sharp vs Brent Sabatini1 shared
- Phillip A Sharp vs Pyott David E I1 shared
Other insiders at the same companies
- Yvonne GreenstreetALNY
- Brent SabatiniVIR
- Aziz SawafVIR
- Pyott David E IALNY
- Amy W SchulmanALNY
- Vanina de VerneuilVIR
- Robert J MoreVIR
- Saira RamasastryVIR
- Timothy CoughlinVIR
- Benjamin CravattALNY
- Janet NapolitanoVIR
- Jeffrey S. HatfieldVIR
- Ramy FaridVIR
- Norbert W BischofbergerVIR
- Colleen F ReitanALNY
Questions about Phillip A Sharp
- What is Phillip A Sharp's role at Alnylam Pharmaceuticals, Inc.?
- Phillip A Sharp reports to the SEC as director at Alnylam Pharmaceuticals, Inc. (ALNY), according to the latest filing on January 24, 2025. Phillip A Sharp has also filed as director at Vir Biotechnology, Inc. (VIR) and director at Syros Pharmaceuticals, Inc. (SYRS).
- How many shares does Phillip A Sharp own?
- After the latest filing that states it, Phillip A Sharp directly owned 121,174 shares of Vir Biotechnology, Inc. (VIR). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Phillip A Sharp bought or sold stock recently?
- The most recent open-market sale was on January 23, 2025: sold 11,250 shares of Alnylam Pharmaceuticals, Inc. (ALNY) for $3.09M at an average of $275.00.
- How do I get alerts when Phillip A Sharp files?
- Follow Phillip A Sharp on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Phillip A Sharp (SEC CIK 0001226295). Totals count each trade once, skipping amendments whose original is on file, from May 25, 2021 on. View on SEC EDGAR · Get this as JSON